Oligogenic inheritance of a human heart disease involving a genetic modifier.

Autor: Gifford CA; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., Ranade SS; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., Samarakoon R; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., Salunga HT; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., de Soysa TY; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., Huang Y; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA., Zhou P; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA., Elfenbein A; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., Wyman SK; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA., Bui YK; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., Cordes Metzler KR; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA., Ursell P; Department of Pathology, University of California, San Francisco, San Francisco, CA 94143, USA., Ivey KN; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA.; Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94143, USA., Srivastava D; Gladstone Institute of Cardiovascular Disease, San Francisco, CA 94158, USA. dsrivastava@gladstone.ucsf.edu.; Roddenberry Stem Cell Center at Gladstone, San Francisco, CA 94158, USA.; Department of Pediatrics, University of California, San Francisco, San Francisco, CA 94143, USA.; Department of Biochemistry and Biophysics, University of California, San Francisco, CA 94143, USA.
Jazyk: angličtina
Zdroj: Science (New York, N.Y.) [Science] 2019 May 31; Vol. 364 (6443), pp. 865-870. Date of Electronic Publication: 2019 May 30.
DOI: 10.1126/science.aat5056
Abstrakt: Complex genetic mechanisms are thought to underlie many human diseases, yet experimental proof of this model has been elusive. Here, we show that a human cardiac anomaly can be caused by a combination of rare, inherited heterozygous mutations. Whole-exome sequencing of a nuclear family revealed that three offspring with childhood-onset cardiomyopathy had inherited three missense single-nucleotide variants in the MKL2 , MYH7 , and NKX2-5 genes. The MYH7 and MKL2 variants were inherited from the affected, asymptomatic father and the rare NKX2-5 variant (minor allele frequency, 0.0012) from the unaffected mother. We used CRISPR-Cas9 to generate mice encoding the orthologous variants and found that compound heterozygosity for all three variants recapitulated the human disease phenotype. Analysis of murine hearts and human induced pluripotent stem cell-derived cardiomyocytes provided histologic and molecular evidence for the NKX2-5 variant's contribution as a genetic modifier.
(Copyright © 2019 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje